Our top pick for
Rayonier Inc is a reit—specialty business based in the US. Rayonier shares (RYN) are listed on the NYSE and all prices are listed in US Dollars. Rayonier employs 353 staff and has a trailing 12-month revenue of around USD$832.4 million.
Since the stock market crash in March caused by coronavirus, Rayonier's share price has had significant negative movement.
Its last market close was USD$27.79, which is 6.49% down on its pre-crash value of USD$29.72 and 74.12% up on the lowest point reached during the March crash when the shares fell as low as USD$15.96.
If you had bought USD$1,000 worth of Rayonier shares at the start of February 2020, those shares would have been worth USD$630.73 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$918.18.
|Latest market close||USD$27.79|
|52-week range||USD$15.6218 - USD$32.0218|
|50-day moving average||USD$27.285|
|200-day moving average||USD$26.4973|
|Wall St. target price||USD$30.83|
|Dividend yield||USD$1.08 (3.83%)|
|Earnings per share (TTM)||USD$0.431|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-15)||N/A|
|1 month (2020-10-26)||3.23%|
|3 months (2020-08-22)||N/A|
|6 months (2020-05-22)||19.32%|
|1 year (2019-11-22)||-8.40%|
|2 years (2018-11-22)||N/A|
|3 years (2017-11-22)||-12.00%|
|5 years (2015-11-22)||N/A|
Valuing Rayonier stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Rayonier's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Rayonier's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 83x. In other words, Rayonier shares trade at around 83x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Rayonier's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 11.592. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Rayonier's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Rayonier's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$253.8 million.
The EBITDA is a measure of a Rayonier's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$832.4 million|
|Operating margin TTM||11.78%|
|Gross profit TTM||USD$153.2 million|
|Return on assets TTM||1.89%|
|Return on equity TTM||2.82%|
|Market capitalisation||USD$3.8 billion|
TTM: trailing 12 months
There are currently 1.9 million Rayonier shares held short by investors – that's known as Rayonier's "short interest". This figure is 14.9% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting Rayonier shares can be evaluated.
Rayonier's "short interest ratio" (SIR) is the quantity of Rayonier shares currently shorted divided by the average quantity of Rayonier shares traded daily (recently around 409607.62711864). Rayonier's SIR currently stands at 4.72. In other words for every 100,000 Rayonier shares traded daily on the market, roughly 4720 shares are currently held short.
However Rayonier's short interest can also be evaluated against the total number of Rayonier shares, or, against the total number of tradable Rayonier shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rayonier's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Rayonier shares in existence, roughly 10 shares are currently held short) or 0.0201% of the tradable shares (for every 100,000 tradable Rayonier shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Rayonier.
Find out more about how you can short Rayonier stock.
Dividend payout ratio: 220.41% of net profits
Recently Rayonier has paid out, on average, around 220.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.83% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Rayonier shareholders could enjoy a 3.83% return on their shares, in the form of dividend payments. In Rayonier's case, that would currently equate to about $1.08 per share.
Rayonier's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Rayonier's most recent dividend payout was on 31 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 16 December 2020 (the "ex-dividend date").
Rayonier's shares were split on a 1339:1000 basis on 30 June 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1339 shares. This wouldn't directly have changed the overall worth of your Rayonier shares – just the quantity. However, indirectly, the new 25.3% lower share price could have impacted the market appetite for Rayonier shares which in turn could have impacted Rayonier's share price.
Over the last 12 months, Rayonier's shares have ranged in value from as little as $15.6218 up to $32.0218. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rayonier's is 0.9977. This would suggest that Rayonier's shares are less volatile than average (for this exchange).
Rayonier is a leading timberland real estate investment trust with assets located in some of the most productive softwood timber growing regions in the United States and New Zealand. As of September 30, 2020, Rayonier owned or leased under long-term agreements approximately 2.7 million acres of timberlands located in the U.S. South (1.75 million acres), U.S. Pacific Northwest (507,000 acres) and New Zealand (416,000 acres). The Company also acts as the managing member in a private equity timber fund business with three funds comprising approximately 141,000 acres. On a ?look-through basis?, the Company's ownership in the timber fund business equates to approximately 17,000 acres.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.